# Plain Language Summary: SUPPORT for Patients and Communities Reauthorization Act of 2025

This bill extends and updates federal programs designed to fight the opioid crisis and related substance abuse problems through 2030. Think of it as renewing the government's commitment to helping people struggling with addiction, preventing overdoses, and supporting recovery. The bill covers three main areas: prevention (stopping addiction before it starts), treatment (helping people get clean), and recovery (supporting people after treatment).

On the prevention side, the bill funds programs that educate pregnant women about the dangers of alcohol and drugs, trains first responders to use overdose-reversal medications like Narcan, and helps communities monitor and respond quickly to overdose outbreaks. It also supports programs addressing fetal alcohol spectrum disorder—a serious condition affecting children born to mothers who drank during pregnancy. The bill includes funding for drug disposal programs so people can safely get rid of old medications, and it supports training for police and emergency workers. Additionally, it funds programs helping young people and families dealing with trauma, which is often connected to substance abuse.

For treatment, the bill expands access to addiction medicine specialists and creates loan repayment programs to attract more doctors and counselors to work in addiction treatment. It funds residential programs specifically for pregnant and postpartum women with substance use disorders, recognizing their unique needs. The bill also supports training programs to help healthcare providers better identify and treat people with both addiction and serious mental illness, and it reviews whether certain addiction medications should be more easily accessible.

The recovery section focuses on helping people rebuild their lives after treatment. It funds peer support programs where people in recovery help others, creates comprehensive recovery centers offering multiple services, and supports job training and employment programs for people recovering from addiction. The bill also includes provisions making it easier for pharmacies to deliver medications to doctors' offices and requires prescribers of controlled substances to complete training on safe prescribing practices.

SUPPORT for Patients and Communities Reauthorization Act of 2025

Guthrie, Brett

SUPPORT for Patients and Communities Reauthorization Act of 2025This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health. For example, the bill reauthorizes for FY2026-FY2030&nbsp;grant and other programs&nbsp;relating to• &nbsp; &nbsp;addressing&nbsp;substance use disorders with respect to pregnant and postpartum women, • &nbsp; &nbsp;prevention and recovery from substance use disorders for youth,&nbsp; • &nbsp; &nbsp;housing for individuals in recovery from substance use disorders, • &nbsp; &nbsp;community organizations facilitating recovery from substance use disorders, • &nbsp; &nbsp;loan repayment for certain health care providers treating substance use disorders,&nbsp; • &nbsp; &nbsp;prevention of overdoses of controlled substances, • &nbsp; &nbsp;treatment of children experiencing psychological trauma, and • &nbsp; &nbsp;mental and behavioral health education and training for medical and allied health students.Also, the bill revises several programs,&nbsp;including by (1) expanding a program that supports resources for first responders to include the purchase of&nbsp;drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for&nbsp;individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center&nbsp;to assist the&nbsp;National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.Additionally, the bill establishes new requirements for&nbsp;HHS, including requirements relating to• &nbsp; &nbsp;protecting the National Suicide Prevention Lifeline program from cybersecurity threats, • &nbsp; &nbsp;establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and • &nbsp; &nbsp;reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.